Sun Pharma Advanced Research Company Limited

Bramhanand Hanamannavar

Nitin Bhalachandra Dharmadhikari

Yashoraj Rupsinh Zala

Abhishek Jain

Umesh Pai

An oral solid dosage form comprising a mixture of compound of formula I and a fusible polymeric carrier; and optionally pharmaceutically acceptable excipients, wherein the mixture is an amorphous dispersion.

Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide

An abuse deterrent oral solid dosage form comprising:

Abuse deterrent oral solid dosage form

An oral solid dosage form comprising a mixture of compound of formula I and a fusible polymeric carrier; and optionally pharmaceutically acceptable excipients, wherein the mixture is an amorphous dispersion. 

An oral, solid dosage form comprising a mixture of compound of formula I and a fusible polymeric carrier; and optionally pharmaceutically acceptable excipients, wherein the mixture is an amorphous dispersion. 

Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N'-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide

Growing community of inventors

Maharashtra, India

Bramhanand Hanamannavar